In conclusion, our results may provide useful clues for developing non-invasive assays evaluating specific metabolites for diagnosis, prognosis, or metabolic-oriented therapy in NOTCH1-dependent leukemias (especially T-ALL). Here, NOTCH1 is linked to acute lymphoblastic leukemia.